Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02234115
Title Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Foreseeacer Pharmaceuticals, Inc.
Indications

prostate carcinoma

Therapies

Leuprolide

Age Groups: adult
Covered Countries USA | DEU | AUT


No variant requirements are available.